Literature DB >> 17579183

Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation: insights into the mechanism of PLC gamma 2 activation.

Ashraf Ragab1, Sonia Séverin, Marie-Pierre Gratacap, Enrique Aguado, Marie Malissen, Martine Jandrot-Perrus, Bernard Malissen, Jeannie Ragab-Thomas, Bernard Payrastre.   

Abstract

Linker for activation of T cells (LAT) is an adaptor protein required for organization of the signaling machinery downstream of the platelet collagen receptor, the glycoprotein VI (GPVI). Here, we investigated the effect of LAT mutations on specific signaling pathways and on platelet functions in response to GPVI triggering by convulxin (Cvx). Using mice containing tyrosine to phenylalanine mutations of the adaptor, we show the crucial role played by the tyrosine residues at positions 175, 195, and 235 in the phosphorylation of LAT and in the whole pattern of protein tyrosine phosphorylation in response to Cvx. These 3 C-terminal tyrosine residues are important to recruit the tyrosine kinase Fyn, which may be involved in LAT phosphorylation. Efficient phosphoinositide 3-kinase (PI3K) activation requires the 3 C-terminal tyrosine residues of LAT but not its tyrosine 136. Interestingly, single mutation of the tyrosine 136 results in the loss of phospholipase C gamma2 (PLCgamma2) activation without affecting its PI3K-dependent membrane association, and is sufficient to impair platelet responses to Cvx. Thus, activation of PLCgamma2 via GPVI is dependent on 2 complementary events: its interaction with the tyrosine 136 of LAT and its membrane location, which itself requires events mediated by the 3 C-terminal tyrosines of LAT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579183     DOI: 10.1182/blood-2007-02-075432

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  Mesenchymal stromal cells lower platelet activation and assist in platelet formation in vitro.

Authors:  Avital Mendelson; Ana Nicolle Strat; Weili Bao; Peter Rosston; Georgia Fallon; Sophie Ohrn; Hui Zhong; Cheryl Lobo; Xiuli An; Karina Yazdanbakhsh
Journal:  JCI Insight       Date:  2019-08-22

2.  A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: the pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP.

Authors:  Wan-Jung Lu; Jie-Jen Lee; Duen-Suey Chou; Thanasekaran Jayakumar; Tsorng-Han Fong; George Hsiao; Joen-Rong Sheu
Journal:  J Mol Med (Berl)       Date:  2011-08-06       Impact factor: 4.599

3.  DREAM plays an important role in platelet activation and thrombogenesis.

Authors:  Kyungho Kim; Alan Tseng; Andrew Barazia; Joseph E Italiano; Jaehyung Cho
Journal:  Blood       Date:  2016-11-30       Impact factor: 22.113

4.  Peptide LSARLAF induces integrin β3 dependent outside-in signaling in platelets.

Authors:  Haixia Niu; Zhenlu Xu; Ding Li; Lin Zhang; Kemin Wang; Donald B Taylor; Junling Liu; T Kent Gartner
Journal:  Thromb Res       Date:  2012-04-05       Impact factor: 3.944

5.  Distinct and overlapping functional roles of Src family kinases in mouse platelets.

Authors:  S Séverin; C A Nash; J Mori; Y Zhao; C Abram; C A Lowell; Y A Senis; S P Watson
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

6.  Cyclic nucleotides and mitogen-activated protein kinases: regulation of simvastatin in platelet activation.

Authors:  Ye-Ming Lee; Wei-Fan Chen; Duen-Suey Chou; Thanasekaran Jayakumar; Ssu-Yu Hou; Jie-Jen Lee; George Hsiao; Joen-Rong Sheu
Journal:  J Biomed Sci       Date:  2010-06-04       Impact factor: 8.410

Review 7.  The Y's that bind: negative regulators of Src family kinase activity in platelets.

Authors:  D K Newman
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

8.  Antiplatelet activity of nifedipine is mediated by inhibition of NF-κB activation caused by enhancement of PPAR-β/-γ activity.

Authors:  Ching-Yu Shih; I-Hsin Lin; James-Cheng Ding; Fu-Chi Chen; Tz-Chong Chou
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

9.  Xanthohumol, a Prenylated Flavonoid from Hops (Humulus lupulus), Prevents Platelet Activation in Human Platelets.

Authors:  Ye-Ming Lee; Kuo-Hsien Hsieh; Wan-Jung Lu; Hsiu-Chu Chou; Duen-Suey Chou; Li-Ming Lien; Joen-Rong Sheu; Kuan-Hung Lin
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-07       Impact factor: 2.629

10.  Novel bioactivity of ellagic Acid in inhibiting human platelet activation.

Authors:  Yi Chang; Wei-Fan Chen; Kuan-Hung Lin; Cheng-Ying Hsieh; Duen-Suey Chou; Li-Jyun Lin; Joen-Rong Sheu; Chao-Chien Chang
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-21       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.